Cost-effectiveness of Internet-based cognitive behavior therapy vs. cognitive behavioral group therapy for social anxiety disorder: Results from a randomized controlled trial

Behaviour Research and Therapy

Volumn 49, Issue 11, 2011, Pages 729-736

  Hedman, Erik ^a   Andersson, Erik ^a   Ljótsson, Brjánn ^a   Andersson, Gerhard ^a,b   Rück, Christian ^a   Lindefors, Nils ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Cognitive behavior therapy; Cost effectiveness analysis; Group therapy; Internet

Indexed keywords

ADULT; ANXIETY DISORDER; ARTICLE; AVOIDANT PERSONALITY DISORDER; CLINICAL ASSESSMENT TOOL; CLINICAL EFFECTIVENESS; COGNITIVE THERAPY; COMORBIDITY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; FEMALE; GROUP THERAPY; HEALTH CARE COST; HUMAN; INTERMETHOD COMPARISON; INTERNET; INTERNET BASED COGNITIVE BEHAVIOR THERAPY; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; OUTCOME ASSESSMENT; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY ANALYSIS; SOCIAL PHOBIA;

ADOLESCENT; ADULT; ANXIETY DISORDERS; COGNITIVE THERAPY; COST-BENEFIT ANALYSIS; FEMALE; HEALTH CARE COSTS; HUMANS; INTERNET; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT PREFERENCE; PSYCHOTHERAPY, GROUP; QUALITY OF LIFE; THERAPY, COMPUTER-ASSISTED;

EID: 80053576212     PISSN: 00057967     EISSN: 1873622X     Source Type: Journal    
DOI: 10.1016/j.brat.2011.07.009     Document Type: Article

References (50)

1. Acarturk C., Smit F., de Graaf R., van Straten A., ten Have M., Cuijpers P. Economic costs of social phobia: a population-based study. Journal of Affective Disorders 2009, 115(3):421-429.
2. Andersson G. Using the internet to provide cognitive behaviour therapy. Behaviour Research and Therapy 2009, 47(3):175-180.
3. Andersson G., Carlbring P., Holmstrom A., Sparthan E., Furmark T., Nilsson-Ihrfelt E., et al. Internet-based self-help with therapist feedback and in vivo group exposure for social phobia: a randomized controlled trial. Journal of Consulting and Clinical Psychology 2006, 74(4):677-686.
4. Barak A., Klein B., Proudfoot J.G. Defining internet-supported therapeutic interventions. Annals of Behavioral Medicine 2009, 38(1):4-17.
5. Berger T., Hohl E., Caspar F. Internet-based treatment for social phobia: a randomized controlled trial. Journal of Clinical Psychology 2009, 65(10):1021-1035.
6. Blanco C., Heimberg R.G., Schneier F.R., Fresco D.M., Chen H., Turk C.L., et al. A placebo-controlled trial of phenelzine, cognitive behavioral group therapy, and their combination for social anxiety disorder. Archives of General Psychiatry 2010, 67(3):286-295.
7. Borkovec T.D., Nau S.D. Credibility of analogue therapy rationales. Journal of Behavior Therapy and Experimental Psychiatry 1972, 3(4):257-260.
8. Bravo Vergel Y., Sculpher M. Quality-adjusted life years. Practical Neurology 2008, 8(3):175-182.
9. Carlbring P., Gunnarsdottir M., Hedensjo L., Andersson G., Ekselius L., Furmark T. Treatment of social phobia: randomised trial of internet-delivered cognitive-behavioural therapy with telephone support. British Journal of Psychiatry 2007, 190:123-128.
10. Chartier M.J., Hazen A.L., Stein M.B. Lifetime patterns of social phobia: a retrospective study of the course of social phobia in a nonclinical population. Depression and Anxiety 1998, 7(3):113-121.
11. Clark D.M., Wells A. A cognitive model of social phobia. Social phobia: Diagnosis, assessment and treatment 1995, 63-93. Guilford Press, New York. R.G. Heimberg, M. Leibowitz, D.A. Hope, F.R. Schneider (Eds.).
12. Dolan P. Modeling valuations for EuroQol health states. Medical Care 1997, 35(11):1095-1108.
13. Drummond M.F., Sculpher M.J., Torrence G.W., O'Brien B.J., Stoddart G.L. Methods for the evaluation of health care programmes 2005, Oxford University Press, Oxford.
14. Efron B., Tibshirani R.J. An introduction to the bootstrap 1993, Chapman & Hall, New York.
15. EuroQol-Group EuroQol - a new facility for the measurement of health-related quality of life. Health Policy 1990, 16(3):199-208.
16. Fehm L., Pelissolo A., Furmark T., Wittchen H.U. Size and burden of social phobia in Europe. European Neuropsychopharmacology 2005, 15(4):453-462.
17. Structured clinical interview for DSM-IV-TR axis I disorders, research version, patient edition 2002, Biometrics Research, New York State Psychiatric Institute, New York. M.B. First, R.L. Spitzer, M. Gibbon, J.B.W. Williams (Eds.).
18. Furmark T., Carlbring P., Hedman E., Sonnenstein A., Clevberger P., Bohman B., et al. Guided and unguided self-help for social anxiety disorder: randomised controlled trial. British Journal of Psychiatry 2009, 195(5):440-447.
19. Furmark T., Tillfors M., Everz P., Marteinsdottir I., Gefvert O., Fredrikson M. Social phobia in the general population: prevalence and sociodemographic profile. Social Psychiatry and Psychiatric Epidemiology 1999, 34(8):416-424.
20. Gould R.A., Buckminster S., Pollack M.H., Otto M.W., Massachusetts L.Y. Cognitive-behavioral and pharmacological treatment for social phobia: a meta-analysis. Clinical Psychology: Science and Practice 1997, 4(4):291-306.
21. Hakkaart-van Roijen L., Donker M.C.H. Manual/iMTA questionnaire for costs associated with psychiatric illness (Tic-P) From. http://hdl.handle.net/1765/1337.
22. Hedman E., Andersson G., Ljótsson B., Andersson E., Rück C., Mörtberg E., et al. Internet-based cognitive behavior therapy vs. cognitive behavioral group therapy for social anxiety disorder: a randomized controlled non-inferiority trial. PLoS ONE 2011, 6(3):e18001.
23. Heimberg R.G., Becker R.E. Cognitive-behavioral group therapy for social phobia. Basic mechanisms and clinical strategies 2002, Guilford Press, New York.
24. Heimberg R.G., Dodge C.S., Hope D.A., Kennedy C.R., Zollo L.J., Becker R.E. Cognitive behavioral group treatment for social phobia: comparison with a credible placebo control. Cognitive Therapy and Research 1990, 14(1):1-23.
25. Heimberg R.G., Horner K.J., Juster H.R., Safren S.A., Brown E.J., Schneier F.R., et al. Psychometric properties of the Liebowitz social anxiety scale. Psychological Medicine 1999, 29(01):199-212.
26. Heimberg R.G., Liebowitz M.R., Hope D.A., Schneier F.R., Holt C.S., Welkowitz L.A., et al. Cognitive behavioral group therapy vs phenelzine therapy for social phobia: 12-week outcome. Archives of General Psychiatry 1998, 55(12):1133-1141.
27. Heuzenroeder L., Donnelly M., Haby M.M., Mihalopoulos C., Rossell R., Carter R., et al. Cost-effectiveness of psychological and pharmacological interventions for generalized anxiety disorder and panic disorder. Australian and New Zealand Journal of Psychiatry 2004, 38(8):602-612.
28. Jacobson N.S., Truax P. Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. Journal of Consulting and Clinical Psychology 1991, 59:12-19.
29. Kessler R.C., Berglund P., Demler O., Jin R., Merikangas K.R., Walters E.E. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication. Archives of General Psychiatry 2005, 62(6):593-602.
30. Layard R., Clark D.M., Knapp M., Mayraz G. Cost-benefit analysis of psychological therapy. National Institute Economic Review 2007, 202:90-98.
31. Ledley D.R., Heimberg R.G., Hope D.A., Hayes S.A., Zaider T.I., Dyke M.V., et al. Efficacy of a manualized and workbook-driven individual treatment for social anxiety disorder. Behavior Therapy 2009, 40(4):414-424.
32. Liebowitz M.R. Social phobia. Modern Problems of Pharmacopsychiatry 1987, 22:141-173.
33. Little J.D.C. A proof for the queuing formula: L=λ W. Operations Research 1961, 9:383-387.
34. Magee W.J., Eaton W.W., Wittchen H.U., McGonagle K.A., Kessler R.C. Agoraphobia, simple phobia, and social phobia in the national comorbidity survey. Archives of General Psychiatry 1996, 53(2):159-168.
35. Patel A., Rendu A., Moran P., Leese M., Mann A., Knapp M. A comparison of two methods of collecting economic data in primary care. Family Practice 2005, 22(3):323-327.
36. Rabin R., Charro F.d. EQ-SD: a measure of health status from the EuroQol Group. Annals of Medicine 2001, 33(5):337-343.
37. Ravens-Sieberer U., Wille N., Badia X., Bonsel G., Burström K., Cavrini G., et al. Feasibility, reliability, and validity of the EQ-5D-Y: results from a multinational study. Quality of Life Research 2010, 19(6):887-897.
38. Reich J., Goldenberg I., Vasile R., Goisman R., Keller M. A prospective follow-along study of the course of social phobia. Psychiatry Research 1994, 54(3):249-258.
39. Roberge P., Marchand A., Reinharz D., Savard P. Cognitive-behavioral treatment for panic disorder with agoraphobia. Behavior Modification 2008, 32(3):333-351.
40. Shapiro D.A., Cavanagh K., Lomas H. Geographic inequity in the availability of cognitive behavioural therapy in England and Wales. Behavioural and Cognitive Psychotherapy 2003, 31(2):185-192.
41. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., et al. The mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry 1998, 59(Suppl. 20):22-33.
42. Smit F., Willemse G., Koopmanschap M., Onrust S., Cuijpers P., Beekman A. Cost-effectiveness of preventing depression in primary care patients: randomised trial. The British Journal of Psychiatry 2006, 188(4):330-336.
43. Soykan C., Ozguven H.D., Gencoz T. Liebowitz social anxiety scale: the Turkish version. Psychological Reports 2003, 93:1059-1069.
44. Svanborg P., Åsberg M. A new self-rating scale for depression and anxiety states based on the Comprehensive Psychopathological Rating Scale. Acta Psychiatrica Scandinavica 1994, 89:21-28.
45. Svanborg P., Åsberg M. A comparison between the Beck depression inventory (BDI) and the self-rating version of the Montgomery Åsberg depression rating scale (MADRS). Journal of Affective Disorders 2001, 64:203-216.
46. Tillfors M., Carlbring P., Furmark T., Lewenhaupt S., Spak M., Eriksson A., et al. Treating university students with social phobia and public speaking fears: internet delivered self-help with or without live group exposure sessions. Depression and Anxiety 2008, 25(8):708-717.
47. Titov N., Andrews G., Johnston L., Schwencke G., Choi I. Shyness programme: longer term benefits, cost-effectiveness, and acceptability. Australian and New Zealand Journal of Psychiatry 2009, 43(1):36-44.
48. Titov N., Andrews G., Schwencke G., Drobny J., Einstein D. Shyness 1: distance treatment of social phobia over the internet. Australian and New Zealand Journal of Psychiatry 2008, 42(7):585-594.
49. Wittchen H.U., Fuetsch M., Sonntag H., Müller N., Liebowitz M. Disability and quality of life in pure and comorbid social phobia. Findings from a controlled study. European Psychiatry 2000, 15(1):46-58.
50. Zanarini M.C., Frankenburg F.R. Attainment and maintenance of reliability of axis I and II disorders over the course of a longitudinal study. Comprehensive Psychiatry 2001, 42(5):369-374.